[Federal Register Volume 78, Number 112 (Tuesday, June 11, 2013)]
[Notices]
[Pages 35052-35053]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-13869]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration; 
Noramco, Inc.

    By Notice dated March 12, 2013, and published in the Federal 
Register on March 20, 2013, 78 FR 17230, Noramco, Inc., 1440 Olympic 
Drive, Athens, Georgia 30601, made application by renewal to the Drug 
Enforcement Administration (DEA) to be registered as an importer of the 
basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Phenylacetone (8501).......................  II
Thebaine (9333)............................  II
Poppy Straw Concentrate (9670).............  II
Tapentadol (9780)..........................  II
------------------------------------------------------------------------


[[Page 35053]]

    The company plans to import Thebaine (9333) analytical reference 
standards for distribution to its customers. The company plans to 
import an intermediate form of Tapentadol (9780) to bulk manufacture 
Tapentadol for distribution to its customers. The company plans to 
import Phenylacetone (8501) and Poppy Straw Concentrate (9670) to 
manufacture other controlled substances.
    The company has withdrawn its request to import the drug code 
Noroxymorphone (9668).
    Comments and requests for hearings on applications to import 
narcotic raw material are not appropriate. 72 FR 3417 (2007).
    DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and 
determined that the registration of Noramco, Inc., to import the basic 
classes of controlled substances is consistent with the public 
interest, and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971, at this 
time. DEA has investigated Noramco, Inc., to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 
Sec.  1301.34, the above named company is granted registration as an 
importer of the basic classes of controlled substances listed.

    Dated: May 24, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-13869 Filed 6-10-13; 8:45 am]
BILLING CODE 4410-09-P